Friday, January 18, 2013

Are You Facing the Growing Pressures of Maximizing the Value of Your Drugs?

 As drug companies are facing growing pressures to maximize the value of their drugs throughout their life cycles and improve the return on investment for their product portfolio, there is major demand to develop new life-cycle management strategies, such as utilizing different drug delivery technologies. Register to attend the 17th Annual Drug Delivery Partnerships, February 6-8, 2013 in San Diego, CA to learn strategies to extend your product life cycle.

Featured Track:
Life Cycle Management, Line Extensions and New Development Strategies for Continued Profitability

Chair: Dr. Ralph Lipp, Former Vice President, Pharmaceutical Sciences R&D, ELI LILLY

Evaluating Platform Technologies in Lieu of Single Molecule Technologies:
When it comes to finding the perfect technology, it’s often a question of macro vs. micro usage. The big question: focus on a cross-platform approach or drill down to a specific molecular application?

In this session, executives:
• Evaluate the ability to determine technologies for large and small molecules at the same time
• Discuss whether testing can occur before phase 3
• Explain how drug delivery companies can aid in the decision-making process

-Julia Rashba-Step, Senior Director, Novel Delivery Technologies, Biotherapeutics R&D, PFIZER
-Keith Horspool, Vice President, Pharmaceutics, BOEHRINGER INGELHEIM

Create Value through Alternate-Route Delivery
This session, lead by Ronald Smith, Executive Director and Head, Product Value Enhancement, MERCK answers the questions:

• What is the strategy behind alternate-route delivery?
• How do you show the value?
• When do you begin the process relative to the molecule and therapeutic area?

Additional Life Cycle Management Sessions Include:

• Create a new OTC brand with Novel Drug Delivery
• Fixed Dose Combinations: Use Predictive Studies to Establish Potential for Success or Failure
• Overcome Challenges Associated with the Development of Drug Delivery-based Generics
• Quicker Feasibility Studies to Speed Up Technology Assessment

To view the 2013 program, download the agenda.

As a reader of the Drug Delivery Partnerships Internationalblog, you get a 15% discount off the standard rate when using code XP1878BLOG to register.  If you have any questions about the agenda or event, please contact Kate Devery at or visit our webpage.

The Drug Delivery Partnerships International Team

The DDP Homepage
DDP Twitter

No comments:

Post a Comment